The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

Researchers discovered that ALPK2, a heart-specific enzyme, may protect against HFpEF by activating TPM1 in heart muscle ...

The following is a summary of “Impact of Exercise on Atrial Functional Mitral Regurgitation and Its Determinants: An Exercise ...

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart ...

A study funded by the National Institutes of Health has found that adults who were hospitalized for a severe infection, such ...

Findings highlight the importance of infection prevention measures and personalized heart failure care.

Patients with rheumatoid arthritis are associated with an increased risk for heart failure, particularly heart failure with preserved ejection fraction.

In particular, severe infections tripled the risk of heart failure with preserved ejection fraction (HFpEF), which occurs ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure ...

Danielle Rasooly, PhD, of the Division of Aging at Brigham and Women’s Hospital, is the co-corresponding author of a paper published in Nature Cardiovascular Research, “Large-scale multi-omics ...